<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05077605</url>
  </required_header>
  <id_info>
    <org_study_id>2020-CHITS-001</org_study_id>
    <secondary_id>2021-A00785-36</secondary_id>
    <nct_id>NCT05077605</nct_id>
  </id_info>
  <brief_title>Effect of Extubation on Respiratory Function</brief_title>
  <acronym>PULMOVISTA</acronym>
  <official_title>Electrical Impedance Tomography: Effect of Extubation on Functional Residual Capacity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The extubation phase is a risky period of anesthesia management. During this step, serious&#xD;
      complications can arise: hypoxemia, laryngospasm, pharyngeal obstruction, pneumonia… In spite&#xD;
      of these complications, extubation and its impact on respiratory function, particularly on&#xD;
      the Functional Residual Capacity (FRC), remains poorly studied because of the difficulty to&#xD;
      make bedside measurements.&#xD;
&#xD;
      The PulmoVista 500 is a clinical routine which provide effective non-invasive bedside&#xD;
      measurements. It would be interesting to evaluate the impact of extubation on respiratory&#xD;
      function, and more specifically FRC changes during and after extubation.&#xD;
&#xD;
      This study will allow a better physiopathological knowledge and a quality improvement patient&#xD;
      extubation management.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to evaluate the variation of functional residual capacity and its&#xD;
      distribution before and after extubation.&#xD;
&#xD;
      Patients with scheduled surgery and receiving general anesthesia with orotracheal intubation&#xD;
      are included and the measurements will be performed in the post-interventional monitoring&#xD;
      room (PICU). EELI data will be collected before extubation and then at T0, then T5, T10, T15&#xD;
      and T20 minutes. No subsequent follow-up is required.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 5, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>End Expiratory Lung Impedance (EELI)</measure>
    <time_frame>Between 2 and 3 hours</time_frame>
    <description>EELI variation before and at different timepoints after extubation: T0, T5, T10, T15 and T20 (min).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tidal volume distribution</measure>
    <time_frame>Between 2 and 3 hours</time_frame>
    <description>Percentage of tidal volume in the different regions of interest before extubation and at different timepoints after it: T0, T5, T10, T15 and T20 (min).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tidal volume distribution depending on patient position</measure>
    <time_frame>Between 2 and 3 hours</time_frame>
    <description>Percentage of tidal volume according to patient position: supine with or without proclivity, lateral or ventral decubitus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tidal volume distribution depending on surgery type and duration</measure>
    <time_frame>Between 2 and 3 hours</time_frame>
    <description>Percentage of tidal volume according to type and duration of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tidal volume distribution depending on ventilatory mode</measure>
    <time_frame>Between 2 and 3 hours</time_frame>
    <description>Percentage of tidal volume according to the ventilatory mode: controlled ventilation, spontaneous ventilation with inspiratory assistance, spontaneous ventilation of extubated patient with or without oxygenation device</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Functional Residual Capacity</condition>
  <arm_group>
    <arm_group_label>Functional residual capacity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Functional residual capacity measure during and after extubation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Functional residual capacity measure by electrical impedance tomography</intervention_name>
    <description>Patient functional residual capacity will be measured by electrical impedance tomography before extubation and then at 0, 10, 15 and 20 min after extubation.</description>
    <arm_group_label>Functional residual capacity</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient over 18 years&#xD;
&#xD;
          -  Patient in operating room for scheduled surgery&#xD;
&#xD;
          -  Patient receiving general anaesthesia with orotracheal intubation&#xD;
&#xD;
          -  Patient given written consent after information&#xD;
&#xD;
          -  Patient covered by social security or equivalent regimen&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient undergoing thoracic and spinal surgery, due to the presence of dressings that&#xD;
             interfere with measurements,&#xD;
&#xD;
          -  Patient who has undergone intracerebral surgery because of possible communication&#xD;
             difficulties upon awakening,&#xD;
&#xD;
          -  Patients with a body mass index (BMI) &gt; 50 (measurements not possible)&#xD;
&#xD;
          -  Pregnant or breastfeeding patient,&#xD;
&#xD;
          -  Patient contraindicated to the use of a thoracic electroimpedancemetry technique:&#xD;
             dressings, wounds, presence of a pacemaker, defibrillator or any other active implant.&#xD;
&#xD;
          -  Patient deprived of liberty by a judicial or administrative decision or patient&#xD;
             subject to a legal protection measure (guardianship, curatorship...)&#xD;
&#xD;
          -  Patient in a period of exclusion from another research protocol&#xD;
&#xD;
          -  Any other reason that, in the opinion of the investigator, could interfere with the&#xD;
             evaluation of study objectives&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clarisse LEGER, Nurse</last_name>
    <role>Study Director</role>
    <affiliation>Hôpital d'instruction des armées Sainte-Anne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Asmaa JOBIC</last_name>
    <phone>04 94 14 55 19</phone>
    <phone_ext>+33</phone_ext>
    <email>asmaa.jobic@ch-toulon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital d'Instruction des Armées de Sainte Anne</name>
      <address>
        <city>Toulon</city>
        <state>Var</state>
        <zip>83100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clarisse LEGER, Nurse</last_name>
      <email>clarisse.leger@intradef.gouv.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 1, 2021</study_first_submitted>
  <study_first_submitted_qc>October 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2021</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Extubation</keyword>
  <keyword>Functional residual capacity</keyword>
  <keyword>Electrical impedance tomography</keyword>
  <keyword>Pulmovista</keyword>
  <keyword>Respiratory function</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

